hydralazine has been researched along with Remission, Spontaneous in 2 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harpey, JP | 1 |
Náhunek, K | 1 |
Svestka, J | 1 |
Kamenická, V | 1 |
Rodová, A | 1 |
1 review available for hydralazine and Remission, Spontaneous
Article | Year |
---|---|
Lupus-like syndromes induced by drugs.
Topics: Antibodies, Antinuclear; Antibody Formation; Arthritis, Rheumatoid; Chlorpromazine; DNA, Single-Stra | 1974 |
1 trial available for hydralazine and Remission, Spontaneous
Article | Year |
---|---|
Preliminary clinical experience with L-dopa in endogenous depressions.
Topics: Clinical Trials as Topic; Depression; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; H | 1972 |